From: "Bonate, Peter"
Subject: [NMusers] When is PK not needed Date:Wed, 11 Jun 2003 09:38:25 -0500 Hello, everyone. I have a question to the collective conscious of the group that is sure to bring out some interesting discussion. In clinical studies, particularly in Phase 3, when it is NOT necessary to collect PK information. Basically, when is enough enough? This question goes right to the heart of why do we collect PK in the first place. Any thoughts on this would be appreciated. Thank you in advance, pete Peter L. Bonate, PhD, FCP Director, Pharmacokinetics ILEX Oncology, Inc 4545 Horizon Hill Blvd San Antonio, TX 78229 phone: 210-949-8662 fax: 210-949-8487 email: firstname.lastname@example.org _______________________________________________________